Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma

NCT00003535 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

High Grade Glioma

Interventions

DRUG: Antineoplaston therapy (Atengenal + Astugenal)

Sponsor

Burzynski Research Institute